Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32543882.
- Also identified by DOI 10.7326/M20-3775 and PMC identifier 7322772.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
According to these authors from the Italian Medicines Agency, “evidence-informed prescribing and clinical trials were beaten off the mark by social media, rumors, and panic in the early phase of the COVID-19 pandemic.” In this article, they describe lessons learned to counteract misleading information and nudge the research community to do high-quality, informative multigroup trials.
Medical subject headings
- Betacoronavirus
- Clinical Trials as Topic
- Coronavirus Infections
- Disease Management
- Emergency Service, Hospital
- Pandemics
- Pneumonia, Viral
- Public Health